Radiation and immunotherapy team up to fight breast cancer in the brain
NCT ID NCT03449238
Summary
This study is testing if combining a targeted radiation treatment (stereotactic radiosurgery) with an immunotherapy drug (pembrolizumab) can better control breast cancer that has spread to the brain. It will involve about 41 adults with metastatic breast cancer who have at least two brain tumors. The main goal is to see if treating one tumor with radiation helps the drug shrink other, untreated tumors in the brain and body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brooklyn Methodist Hospital - NewYork Presbyterian
RECRUITINGNew York, New York, 11215, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
New York Presbyterian Hospital - Queens
RECRUITINGNew York, New York, 11355, United States
Contact
Contact Email: •••••@•••••
-
Weill Cornell Medicine
RECRUITINGNew York, New York, 10065, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.